Related references
Note: Only part of the references are listed.EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2021)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2021)
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
Konsta Kukkonen et al.
CANCERS (2021)
Epigenetics in prostate cancer: clinical implications
Vincenza Conteduca et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)
Epigenetic modifications in prostate cancer
Masahiro Sugiura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2021)
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation
Ieva Rauluseviciute et al.
BMC MEDICAL GENOMICS (2020)
Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review
Walter Artibani et al.
UROLOGIA INTERNATIONALIS (2018)
The importance of DNA methylation in prostate cancer development
Charles E. Massie et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
The emerging role of RUNX3 in cancer metastasis
Feifei Chen et al.
ONCOLOGY REPORTS (2016)
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
Filippo Martignano et al.
DISEASE MARKERS (2016)
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
Fatima H. Karzai et al.
BJU INTERNATIONAL (2015)
Prognostic Value of RASSF1 Promoter Methylation in Prostate Cancer
Kristina Daniunaite et al.
JOURNAL OF UROLOGY (2014)
GSTP1 Promoter Methylation is Associated with Recurrence in Early Stage Prostate Cancer
Leonel Maldonado et al.
JOURNAL OF UROLOGY (2014)
APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis
Yang Chen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors
Diana Romero et al.
CANCER RESEARCH (2011)
Methylation-Mediated Repression of GADD45α in Prostate Cancer and Its Role as a Potential Therapeutic Target
Kavitha Ramachandran et al.
CANCER RESEARCH (2009)
Genetic and Epigenetic Inactivation of TNFRSF10C in Human Prostate Cancer
Yu Cheng et al.
PROSTATE (2009)
Epigenetic mechanisms in the biology of prostate cancer
Wolfgang A. Schulz et al.
SEMINARS IN CANCER BIOLOGY (2009)
Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy
Patrick J. Bastian et al.
EUROPEAN UROLOGY (2007)
Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma
TY Kim et al.
LABORATORY INVESTIGATION (2004)
A quantitative promoter methylation profile of prostate cancer
C Jerónimo et al.
CLINICAL CANCER RESEARCH (2004)
Molecular biomarker in prostate cancer: The role of CpG island hypermethylation
PJ Bastian et al.
EUROPEAN UROLOGY (2004)
Molecular detection of prostate cancer:: A role for GSTP1 hypermethylation
R Henrique et al.
EUROPEAN UROLOGY (2004)
Frequent hypermethylation of the RASSF1A gene in prostate cancer
LM Liu et al.
ONCOGENE (2002)
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer
P Wikström et al.
PROSTATE (2002)
Share Paper
